| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 56.155 | 71.731 | 65.604 | 60.161 | 3.615 | 9.851 | 21.099 | 23.470 | 24.978 | 16.183 |
| Total Income - EUR | 56.155 | 71.731 | 65.604 | 60.161 | 3.615 | 9.851 | 21.099 | 23.470 | 24.978 | 16.183 |
| Total Expenses - EUR | 41.453 | 52.610 | 51.829 | 57.688 | 7.182 | 5.924 | 6.673 | 6.008 | 6.108 | 3.898 |
| Gross Profit/Loss - EUR | 14.701 | 19.121 | 13.774 | 2.472 | -3.567 | 3.928 | 14.426 | 17.462 | 18.870 | 12.285 |
| Net Profit/Loss - EUR | 13.017 | 16.969 | 11.806 | 667 | -3.675 | 3.632 | 13.869 | 16.772 | 15.850 | 10.306 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Vitalys - Medicina De Elită Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.748 | 1.505 | 503 | 164 | 1.213 | 1.514 | 406 | 0 | 579 | 115 |
| Current Assets | 5.420 | 16.928 | 11.830 | 7.700 | 2.177 | 5.522 | 14.330 | 16.970 | 16.021 | 10.239 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.886 | 0 | 36 |
| Cash | 5.420 | 16.928 | 11.830 | 7.700 | 2.177 | 5.522 | 14.330 | 4.084 | 16.021 | 10.203 |
| Shareholders Funds | 913 | 17.873 | 11.859 | 719 | -2.970 | 718 | 14.571 | 16.820 | 15.899 | 10.354 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.256 | 560 | 474 | 7.146 | 6.361 | 6.318 | 164 | 149 | 702 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Vitalys - Medicina De Elită Srl